Global Antiplatelet Drugs Market Is Estimated To Witness High Growth Owing To Increasing Prevalence of Cardiovascular Diseases
Antiplatelet Drugs Market The global antiplatelet drugs market is estimated to be valued at US$ 2,153.4 million in 2022 and is expected to exhibit a CAGR of 7.8% over the forecast period 2022-2030, as highlighted in a new report published by Coherent Market Insights. Market Overview: Antiplatelet drugs are medications that inhibit the activation and aggregation of platelets, preventing the formation of blood clots. These drugs are commonly used in the prevention and treatment of cardiovascular diseases such as heart attacks, strokes, and peripheral arterial diseases. The increasing prevalence of cardiovascular diseases globally is driving the demand for antiplatelet drugs. These drugs help reduce the risk of blood clot formation, thereby reducing the chances of heart attacks and strokes. The need for such products in the market is crucial as they can potentially save lives and improve patient outcomes. Market Key Trends: One key trend in the global antiplatelet drugs market is t...